Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection
- PMID: 39785092
- PMCID: PMC11715144
- DOI: 10.1111/pai.70026
Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection
Keywords: acquired general lipodystrophy; anti‐PLIN1 antibodies; autoimmune hepatitis; autoimmune lipodystrophy; autoimmunity; perlipin1.
Conflict of interest statement
The authors have no competing interest to disclose in relationship with the present manuscript.
Figures


References
-
- Savage DB. Perilipin 1 antibodies in patients with acquired generalized lipodystrophy. Diabetes. 2023;72(1):16‐18. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources